In 2023, state health departments in Florida and Texas reported the first locally acquired cases of mosquito-transmitted malaria in nearly 20 years. Just nine years earlier, Zika virus, a new tropical ...

The biotech is developing drugs that target the biology of aging to treat obesity, cardiovascular disease, and more ...

Brian Lian founded publicly traded Viking Therapeutics to focus on metabolic diseases. With obesity drugs in development and ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

The pharmaceutical industry has long operated on a one-size-fits-all model, developing drugs primarily tested on, and thus best suited for, people of European descent. This approach ignores — and ...

When researchers are making a new drug, they face years of work in development and trials. Then, in about 90 per cent of cases, the outcome is a failure and they slide back, snakes-and-ladders style, ...

The research and development of new pharmaceuticals is increasingly an international affair, something that recent discussion about how tariffs might affect drug prices has made very clear. And even ...

The Congressional Budget Office (CBO) informs Congress about the costs or revenue changes associated with proposed legislation, a challenging enough task on its own. Sometimes, the CBO is asked to ...

The next wave of obesity drugs is coming soon. Drug companies are racing to develop GLP-1 drugs following the blockbuster success of Novo Nordisk’s Ozempic and Wegovy and Eli Lilly’s Mounjaro and ...

The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...